Asian markets opened higher, following a global rally that pushed world indexes to new records, despite the US entering its first government shutdown in nearly seven years. Japan, South Korea, and Australia all traded in positive territory, with the chip and technology sectors providing key support. In Seoul, Samsung Electronics and SK Hynix surged after signing initial supply deals for OpenAI's "Stargate" project. On Wall Street, the S&P 500 rose 0.3% and the Nasdaq 100 added 0.5%, helping lift the MSCI global benchmark index to a new high. In the bond market, Treasuries maintained...
The Nikkei 225 index rose 1.0% to 44,990.71 in early trading, following a record-breaking rally on Wall Street overnight. The market appeared calm despite ongoing concerns about the US government shutdown. The gains were led by pharmaceutical and chip stocks. Chugai Pharmaceutical rose 3.2%, while Lasertec gained 4.4%, amid positive sentiment in the healthcare and technology sectors. On the currency market, USD/JPY was at 147.24, virtually unchanged from 147.34 at the close in Tokyo on Wednesday. The stable rupiah/yen helped maintain interest in export-oriented stocks. Looking ahead,...
Wall Street's indexes closed at record highs on Wednesday, buoyed by strong sector performance and optimism that the US government shutdown will be brief. Investors shrugged off the first day of the shutdown and weaker-than-expected private payrolls data, with the S&P 500 gaining 0.3%, the Nasdaq 100 rising 0.5%, and the Dow adding 43 points. Health-care stocks led the advance, driven by sharp gains in Regeneron (+6.7%), Moderna (+6.8%), Eli Lilly (+8.2%), and AbbVie (+5.5%), while optimism over Pfizer's (+2.2%) deal with the White House on Medicaid drug pricing provided additional...
Europe's STOXX 600 closed at a record high on Wednesday, with healthcare stocks leading the way after a U.S.-Pfizer deal reduced uncertainty in the sector, while investors digested the beginning of a U.S. government shutdown. The pan-European STOXX 600 surged 1.2% to log its biggest one-day percentage gain since July 23. Most regional bourses were also trading higher, with London's FTSE 100 at a record high. Healthcare stocks jumped 5.4%, marking their biggest one-day performance since November 2008. On Tuesday, Pfizer agreed to lower prescription drug prices in the U.S. Medicaid programme...
European shares were flat on Wednesday, with gains in heavyweight healthcare stocks offsetting the decline in the broader market, as investors fretted over a potential delay in the closely-watched U.S. jobs data. The pan-European STOXX 600 held steady at 557.9 points by 0711 GMT, after posting its third successive monthly gain in September. Local bourses were mixed. Germany's DAX was down 0.5%, while the UK's FTSE 100 climbed 0.2% to an all-time high. Healthcare stocks jumped 2.7% after Pfizer and U.S. President Donald Trump on Tuesday said they had cut a deal in which the drugmaker...